Related Experiment Video
Updated: May 1, 2026
07:20
A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
9.5K
Anti-NMDA Receptor Encephalitis in Psychiatry
Matthew S Kayser1, Josep Dalmau2
1Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Current Psychiatry Reviews
|April 15, 2014
Summary
Anti-NMDA receptor encephalitis is an autoimmune disorder attacking brain receptors, often impacting young women. Early psychiatric symptoms can precede severe neurologic deficits, but immunotherapy offers effective treatment.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Anti-NMDA receptor encephalitis is an autoimmune disorder targeting N-methyl-D-aspartate receptors in the brain.
- The condition presents with distinct neurologic and psychiatric manifestations, often requiring mental health intervention.
- Understanding the phased progression of symptoms is crucial for timely diagnosis and management.
Purpose of the Study:
- To provide an updated review of anti-NMDA receptor encephalitis.
- To highlight the critical role of psychiatric assessment in diagnosis, understanding symptomatology, and guiding treatment.
- To emphasize the effectiveness of immunotherapy while acknowledging challenges in managing psychiatric symptoms.
Main Methods:
- Literature review of anti-NMDA receptor encephalitis.
- Analysis of clinical presentation, including neurologic and psychiatric features.
- Discussion of diagnostic criteria and therapeutic approaches, focusing on immunotherapy.
Main Results:
- The disorder involves antibodies attacking NMDA receptors, leading to characteristic neurologic deficits and prominent psychiatric symptoms.
- Illness progression includes distinct phases: early psychosis, fluctuating consciousness with neurologic involvement, and protracted cognitive/behavioral deficits.
- Young women are the most commonly affected demographic, with ovarian teratomas sometimes associated.
Conclusions:
- Anti-NMDA receptor encephalitis requires a multidisciplinary approach, integrating neurology and psychiatry.
- Psychiatric symptoms are a key diagnostic clue and a significant challenge in patient management.
- Immunotherapy is an effective treatment, but comprehensive care is essential for optimal patient outcomes.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
15.6K
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
5.2K
Related Concept Videos
01:26Encephalitis ll: Pathophysiology
22
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
01:19Encephalitis l: Introduction
15
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
01:14Antiepileptic Drugs: Glutamate Antagonists
1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
01:29Hepatic Encephalopathy
53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53
01:25Arboviral Encephalitis
59
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
59
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
926
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
926